Your search for dabigatran returned 1 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Lea Eslava-Kim, PharmD remove
Drugs in the Pipeline remove

Your search for dabigatran returned 1 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Rapid Reversal Seen With Idarucizumab in Pradaxa-Treated Patients

Boehringer Ingelheim presented positive results of its Phase 3 RE-VERSE AD study for idarucizumab as a reversal agent for the anticoagulant effect of Pradaxa (dabigatran) in patients needing emergency surgery or for life-threatening or uncontrolled bleeding events.